FRAZER, PA: Cephalon restructured its communications function and hired Natalie de Vane to lead global corporate communications for the biopharmaceutical company.
De Vane, most recently the VP of specialty care communications at Pfizer and a former VP of corporate affairs for Wyeth Nutrition, was named senior director of global corporate communications at Cephalon.
Her responsibilities include external and internal communications, media relations, corporate brand management, and management of the company website.
She reports to the company's VP of public affairs Fritz Bittenbender.
"It's a unique opportunity," said de Vane. "It's one of the top 10 biotech companies and it's growing."
De Vane's appointment, effective January 3, fills the role vacated by Sheryl Williams in 2009.
Williams served as Cephalon's VP of corporate and public affairs before she joined the Center for Neuroscience & Society at the University of Pennsylvania as director of neuroscience policy.
Candace Steele Flippin, senior director of product communications at Cephalon and a former colleague of de Vane's at Wyeth, called her a "superb communicator."
In addition to de Vane's appointment, Cephalon restructured the communications function in November to house corporate communications, government relations, corporate affairs, and advocacy within the public affairs division.
Bittenbender's previous title was VP of government and corporate affairs.
The company's product communications team, which previously reported to Williams, now reports to the US commercial function – the same division that funds product communications, according to Steele Flippin. She leads product PR strategy, commercial internal communications, media relations, lifecycle communications, and issues management for the US pharmaceutical organization.
The announcement of the restructuring comes less than a month after Cephalon named Kevin Buchi its CEO. Buchi, former CFO for Cephalon, has been handling CEO responsibilities since August 2009.